November 4, 2015
Power morcellator lawsuits filed in federal court against Johnson & Johnson’s Ethicon unit have been consolidated for pretrial proceedings. The United States Judicial Panel on Multidistrict Litigation transferred the Ethicon lawsuits to the federal district court for the District of Kansas. That court, said the panel, is centrally located in the middle of the country and the judge has “a wealth of MDL experience.” The Ethicon morcellator MDL is entitled IN RE: Ethicon, Inc., Power Morcellator Products Liability Litigation.
For years, medical device makers promoted their power morcellators for use in laparoscopic hysterectomies and myomectomies to remove uterine fibroid tumors. In 2014, the U.S. Food and Drug Administration (FDA) cautioned that morcellators should not be used for most women requiring such surgeries because of the risk of spreading undetected uterine cancer. Ethicon’s power morcellator, which was the market leader at the time, was withdrawn from the market. Many hospitals have greatly limited the use of power morcellators and several insurers now require express pre-approval for any surgery involving a morcellator.
The recent MDL Order consolidated at least 28 federal morcellator lawsuits against Johnson & Johnson’s Ethicon unit filed in several states, including:
The panel noted that all the Ethicon lawsuits involved common issues about Ethicon’s testing and promoting of the power morcellators. In addition, the cases would all raise the same issues about Ethicon’s knowledge of the risks for women undergoing myomectomies and hysterectomies.
The MDL panel refused, however, to consolidate lawsuits against other power morcellator manufacturers, such as Karl Storz and Gyrus, with the Ethicon power morcellator claims. The issues surrounding different manufacturers’ testing, design and warnings were too different to warrant a mass consolidation involving several defendants.
We understand that injuries caused by power morcellators are personal and they’re sensitive. That’s why we’ve assembled a legal team, most of whom are women, to provide our morcellator clients with compassionate and aggressive representation throughout the entire course of litigation. To learn more about Waters Kraus Paul & Siegel, or to have one of our attorneys review your potential case, contact us by email or call our medical device lawyers, like Kyla Cole in our Texas office, at 800.226.9880.
Our Results
Historic settlement for over 1,300 survivors of clergy and adult abuse within the Roman Catholic Archdiocese of Los Angeles, marking a pivotal moment for justice.
A Philadelphia jury awarded a record verdict against ExxonMobil for failing to warn about cancer risks due to benzene in its petroleum products.
Confidential settlement for the wife of a Rhode Island man who died of mesothelioma cancer after exposure to window glazing compound contaminated with asbestos.
That’s the first question everyone asks. The truth is it’s impossible to know. But we can tell you this. Waters Kraus Paul & Siegel has what it takes to fight against big corporate interests and win. That’s why we’ve recovered more than $1.3 billion for clients like you.
